BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alibolandi M, Hoseini F, Mohammadi M, Ramezani P, Einafshar E, Taghdisi SM, Ramezani M, Abnous K. Curcumin-entrapped MUC-1 aptamer targeted dendrimer-gold hybrid nanostructure as a theranostic system for colon adenocarcinoma. Int J Pharm 2018;549:67-75. [PMID: 30048777 DOI: 10.1016/j.ijpharm.2018.07.052] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Hasannia M, Abnous K, Taghdisi SM, Nekooei S, Ramezani M, Alibolandi M. Synthesis of doxorubicin-loaded peptosomes hybridized with gold nanorod for targeted drug delivery and CT imaging of metastatic breast cancer. J Nanobiotechnology 2022;20:391. [PMID: 36045404 DOI: 10.1186/s12951-022-01607-2] [Reference Citation Analysis]
2 Mahmoudi A, Kesharwani P, Majeed M, Teng Y, Sahebkar A. Recent advances in nanogold as a promising nanocarrier for curcumin delivery. Colloids Surf B Biointerfaces 2022;215:112481. [PMID: 35453063 DOI: 10.1016/j.colsurfb.2022.112481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Babaei M, Abnous K, Nekooei S, Mohammad Taghdisi S, Amel Farzad S, Ramezani M, Alibolandi M. Synthesis of manganese-incorporated polycaplactone-poly (glyceryl methacrylate) theranostic smart hybrid polymersomes for efficient colon adenocarcinoma treatment. Int J Pharm 2022;:121963. [PMID: 35764261 DOI: 10.1016/j.ijpharm.2022.121963] [Reference Citation Analysis]
4 Jan Z, Mollazadeh S, Abnous K, Taghdisi SM, Danesh A, Ramezani M, Alibolandi M. Targeted Delivery Platforms for the Treatment of Multiple Sclerosis. Mol Pharm 2022. [PMID: 35501974 DOI: 10.1021/acs.molpharmaceut.1c00892] [Reference Citation Analysis]
5 Sheikh A, Md S, Alhakamy NA, Kesharwani P. Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121751] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zahiri M, Falsafi M, Lamei K, Abnous K, Taghdisi SM, Ramezani M, Alibolandi M. Targeted biomimetic hollow mesoporous organosilica nanoparticles for delivery of doxorubicin to colon adenocarcinoma: In vitro and in vivo evaluation. Microporous and Mesoporous Materials 2022. [DOI: 10.1016/j.micromeso.2022.111841] [Reference Citation Analysis]
7 Amekyeh H, Alkhader E, Sabra R, Billa N. Prospects of Curcumin Nanoformulations in Cancer Management. Molecules 2022;27:361. [PMID: 35056675 DOI: 10.3390/molecules27020361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
8 Liu M, Wang L, Lo Y, Shiu SC, Kinghorn AB, Tanner JA. Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging. Cells 2022;11:159. [DOI: 10.3390/cells11010159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
9 Sahranavard M, Shahriari M, Abnous K, Hadizadeh F, Taghdisi SM, Zolfaghari R, Ramezani M, Alibolandi M. Design and synthesis of targeted star-shaped micelle for guided delivery of camptothecin: In vitro and in vivo evaluation. Mater Sci Eng C Mater Biol Appl 2021;131:112529. [PMID: 34857308 DOI: 10.1016/j.msec.2021.112529] [Reference Citation Analysis]
10 Navyatha B, Nara S. Gold nanotheranostics: future emblem of cancer nanomedicine. Nanobiomedicine (Rij) 2021;8:18495435211053945. [PMID: 34737836 DOI: 10.1177/18495435211053945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wahab S, Alshahrani MY, Ahmad MF, Abbas H. Current trends and future perspectives of nanomedicine for the management of colon cancer. Eur J Pharmacol 2021;910:174464. [PMID: 34474029 DOI: 10.1016/j.ejphar.2021.174464] [Reference Citation Analysis]
12 Sheikh A, Md S, Kesharwani P. RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy. J Control Release 2021;340:221-42. [PMID: 34757195 DOI: 10.1016/j.jconrel.2021.10.028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Falsafi M, Zahiri M, Saljooghi AS, Abnous K, Taghdisi SM, Sazgarnia A, Ramezani M, Alibolandi M. Aptamer targeted red blood cell membrane-coated porphyrinic copper-based MOF for guided photochemotherapy against metastatic breast cancer. Microporous and Mesoporous Materials 2021;325:111337. [DOI: 10.1016/j.micromeso.2021.111337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sheikh A, Kesharwani P. An insight into aptamer engineered dendrimer for cancer therapy. European Polymer Journal 2021;159:110746. [DOI: 10.1016/j.eurpolymj.2021.110746] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
15 Micale N, Molonia MS, Citarella A, Cimino F, Saija A, Cristani M, Speciale A. Natural Product-Based Hybrids as Potential Candidates for the Treatment of Cancer: Focus on Curcumin and Resveratrol. Molecules 2021;26:4665. [PMID: 34361819 DOI: 10.3390/molecules26154665] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
16 Morshedi K, Borran S, Ebrahimi MS, Masoud Khooy MJ, Seyedi ZS, Amiri A, Abbasi-Kolli M, Fallah M, Khan H, Sahebkar A, Mirzaei H. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review. Phytother Res 2021. [PMID: 34173992 DOI: 10.1002/ptr.7119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Hani U, Honnavalli YK, Begum MY, Yasmin S, Osmani RAM, Ansari MY. Colorectal cancer: A comprehensive review based on the novel drug delivery systems approach and its management. Journal of Drug Delivery Science and Technology 2021;63:102532. [DOI: 10.1016/j.jddst.2021.102532] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Bagheri E, Alibolandi M, Abnous K, Taghdisi SM, Ramezani M. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles. J Mater Chem B 2021;9:1351-63. [PMID: 33447840 DOI: 10.1039/d0tb01960g] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Khan FA, Albalawi R, Pottoo FH. Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment. Med Res Rev 2021. [PMID: 33891325 DOI: 10.1002/med.21809] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
20 Sethiya A, Agarwal DK, Agarwal S. Current Trends in Drug Delivery System of Curcumin and its Therapeutic Applications. Mini Rev Med Chem 2020;20:1190-232. [PMID: 32348221 DOI: 10.2174/1389557520666200429103647] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Mignani S, Shi X, Ceña V, Rodrigues J, Tomas H, Majoral J. Engineered non-invasive functionalized dendrimer/dendron-entrapped/complexed gold nanoparticles as a novel class of theranostic (radio)pharmaceuticals in cancer therapy. Journal of Controlled Release 2021;332:346-66. [DOI: 10.1016/j.jconrel.2021.03.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
22 Mignani S, Shi X, Ceña V, Rodrigues J, Tomas H, Majoral J. Engineered non-invasive functionalized dendrimer/dendron-entrapped/complexed gold nanoparticles as a novel class of theranostic (radio)pharmaceuticals in cancer therapy. Journal of Controlled Release 2021;332:346-66. [DOI: 10.1016/j.jconrel.2021.03.003] [Reference Citation Analysis]
23 Vinchhi P, Patel MM. Triumph against cancer: invading colorectal cancer with nanotechnology. Expert Opin Drug Deliv 2021;18:1169-92. [PMID: 33567909 DOI: 10.1080/17425247.2021.1889512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Flanagan SP, Fogel R, Edkins AL, Ho LSJ, Limson J. Nonspecific nuclear uptake of anti-MUC1 aptamers by dead cells: the role of cell viability monitoring in aptamer targeting of membrane-bound protein cancer biomarkers. Anal Methods 2021;13:1191-203. [PMID: 33605950 DOI: 10.1039/d0ay01878c] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sanati S, Taghavi S, Abnous K, Taghdisi SM, Babaei M, Ramezani M, Alibolandi M. Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinoma. Gene Ther 2021. [PMID: 33633357 DOI: 10.1038/s41434-021-00234-0] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
26 Moorthy H, Govindaraju T. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine. ACS Appl Bio Mater 2021;4:1115-39. [PMID: 35014470 DOI: 10.1021/acsabm.0c01319] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
27 Gokulu SG, Yurt Kilcar A, Bilgi A, Karatay KB, Yildirim N, Kayas C, Biber Muftuler FZ, Terek MC. Investigation of nanoformulation and incorporation potential of radiolabeled curcumin using HeLa and MDAH-2774 cells. J Radioanal Nucl Chem 2021;327:299-305. [DOI: 10.1007/s10967-020-07509-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Falsafi M, Saljooghi AS, Abnous K, Taghdisi SM, Ramezani M, Alibolandi M. Smart metal organic frameworks: focus on cancer treatment. Biomater Sci 2021;9:1503-29. [DOI: 10.1039/d0bm01839b] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Fu Z, Xiang J. Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy. Int J Mol Sci 2020;21:E9123. [PMID: 33266216 DOI: 10.3390/ijms21239123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
30 Charbgoo F, Taghdisi SM, Yazdian‐robati R, Abnous K, Ramezani M, Alibolandi M. Aptamer‐Incorporated Nanoparticle Systems for Drug Delivery. In: Rai M, Razzaghi‐abyaneh M, Ingle AP, editors. Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment. Wiley; 2020. pp. 95-112. [DOI: 10.1002/9781119671732.ch5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Moghadam SMM, Alibolandi M, Babaei M, Mosafer J, Saljooghi AS, Ramezani M. Fabrication of deferasirox-decorated aptamer-targeted superparamagnetic iron oxide nanoparticles (SPION) as a therapeutic and magnetic resonance imaging agent in cancer therapy. J Biol Inorg Chem 2021;26:29-41. [PMID: 33156416 DOI: 10.1007/s00775-020-01834-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
32 Li H, Sun J, Zhu H, Wu H, Zhang H, Gu Z, Luo K. Recent advances in development of dendritic polymer-based nanomedicines for cancer diagnosis. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1670. [PMID: 32949116 DOI: 10.1002/wnan.1670] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
33 Koudrina A, DeRosa MC. Advances in Medical Imaging: Aptamer- and Peptide-Targeted MRI and CT Contrast Agents. ACS Omega 2020;5:22691-701. [PMID: 32954116 DOI: 10.1021/acsomega.0c02650] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
34 Bagheri E, Abnous K, Farzad SA, Taghdisi SM, Ramezani M, Alibolandi M. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer. Life Sci 2020;261:118369. [PMID: 32882265 DOI: 10.1016/j.lfs.2020.118369] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
35 Cabeza L, Perazzoli G, Mesas C, Jiménez-Luna C, Prados J, Rama AR, Melguizo C. Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents. AAPS PharmSciTech 2020;21:178. [PMID: 32591920 DOI: 10.1208/s12249-020-01731-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
36 Rajpoot K, Jain SK. Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal cancer: A dual-targeted approach. International Journal of Biological Macromolecules 2020;151:830-44. [DOI: 10.1016/j.ijbiomac.2020.02.132] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
37 Hu X, Kwon N, Yan K, Sedgwick AC, Chen G, He X, James TD, Yoon J. Bio‐Conjugated Advanced Materials for Targeted Disease Theranostics. Adv Funct Mater 2020;30:1907906. [DOI: 10.1002/adfm.201907906] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
38 Carvalho MR, Reis RL, Oliveira JM. Dendrimer nanoparticles for colorectal cancer applications. J Mater Chem B 2020;8:1128-38. [PMID: 31971528 DOI: 10.1039/c9tb02289a] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 12.5] [Reference Citation Analysis]
39 Ghaffari M, Dehghan G, Baradaran B, Zarebkohan A, Mansoori B, Soleymani J, Ezzati Nazhad Dolatabadi J, Hamblin MR. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells. Colloids Surf B Biointerfaces 2020;188:110762. [PMID: 31911391 DOI: 10.1016/j.colsurfb.2019.110762] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
40 Si P, Shi J, Zhang P, Wang C, Chen H, Mi X, Chu W, Zhai B, Li W. MUC-1 recognition-based activated drug nanoplatform improves doxorubicin chemotherapy in breast cancer. Cancer Lett 2020;472:165-74. [PMID: 31857156 DOI: 10.1016/j.canlet.2019.12.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Manatunga DC, Godakanda VU, de Silva RM, de Silva KMN. Recent developments in the use of organic-inorganic nanohybrids for drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1605. [PMID: 31826328 DOI: 10.1002/wnan.1605] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
42 Kesharwani P, Choudhury H, Meher JG, Pandey M, Gorain B. Dendrimer-entrapped gold nanoparticles as promising nanocarriers for anticancer therapeutics and imaging. Progress in Materials Science 2019;103:484-508. [DOI: 10.1016/j.pmatsci.2019.03.003] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 18.0] [Reference Citation Analysis]